Polypeptide N-Acetylgalactosaminyltransferase 9 (GALNT9) Antibody

This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. This gene is expressed specifically in the brain, with highest expression in the cerebellum. Multiple transcript variants encoding different isoforms have been found for this gene.

Target	Polypeptide N-Acetylgalactosaminyltransferase 9 (GALNT9)
Clonality	Polyclonal
Reactivity	Human
Tested Applications	ELISA, WB, IHC
Host	Rabbit
Recommended dilutions	WB: 1/1000, IHC-P: 1/100. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 296-322 amino acids from the Central region of human GALNT9.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	Q9HCQ5 (UniProt, ExPASy)
UniProt Secondary AC	Q52LR8, Q6NT54, Q8NFR1
UniProt Entry Name	GALT9_HUMAN
Gene Symbol	GALNT9
String	9606.ENSP00000380488
Molecular Weight	Calculated MW: 68.4 kDa
Buffer	PBS containing 0.09% sodium azide.
Specificity	Predicted to react with Monkey GALNT9.
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Polypeptide N-Acetylgalactosaminyltransferase 9 (GALNT9)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue